IPCALABNSEIPCA Laboratories Limited· PharmaceuticalsLowNeutral
Announced Tue, 5 Aug · 17:22 IST

IPCA Laboratories Limited has informed the Exchange about Schedule of meet

Board & Shareholder Meetings View source PDF

IPCALAB · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve

Awaiting price reaction for this filing.

AI summary

Ipca Laboratories Limited has informed the stock exchanges about a conference call scheduled for Tuesday, 12th August 2025 at 15:30 hrs IST to discuss its Q1 FY26 earnings and business update. The call follows the company's Q1 FY26 financial results announcement on Monday, 11th August 2025. The management will be represented by Managing Director Mr. A K Jain and Corporate Counsel & Company Secretary Mr. Harish Kamath. The call will be hosted by Dam Capital Advisors Ltd., with universal dial-in numbers and a Diamond Passcode link provided for investors and analysts.

Likely market impact

This is a routine regulatory disclosure informing investors and analysts about the upcoming earnings call. It signals that Q1 FY26 results are imminent (expected on 11th August 2025), which is a key event for tracking the company's quarterly performance. No immediate impact on stock price is expected from the announcement itself, but it sets the stage for potential volatility around the earnings release.